Lipid levels in serum and cancerous tissues of colorectal cancer patients

Table 1 Comparison of serum lipid levels in patients with colorectal cancer, patients with benign colorectal disease and healthy participants (mmol/L)

Items	Patients with colorectal cancer (n = 260)	Patients with benign colorectal disease (n = 70)	Healthy participants (n = 300)	P value
TCH	4.8 ± 0.912	5.9 ± 0.7	5.7 ± 0.9	< 0.05 < 0.01
FCH	1.9 ± 0.412	1.3 ± 0.3	1.2 ± 0.4	< 0.01 < 0.01
TG	1.5 ± 0.9	1.4 ± 0.5	1.5 ± 0.7	> 0.05
HDL-C	1.4 ± 0.4	1.4 ± 0.2	1.4 ± 0.3	>0.05
LDL-C	3.1 ± 0.812	3.9 ± 0.8	4.3 ± 0.8	< 0.01 < 0.01
ApoA-I (g/L)	1.4 ± 0.212	2.1 ± 0.4	2.2 ± 1.5	< 0.01 < 0.001
ApoB (g/L)	0.9 ± 0.312	1.8 ± 0.2	1.7 ± 0.3	< 0.01 < 0.01

¹Comparison between patients with colorectal cancer and patients with benign colorectal disease, P < 0.05 and P < 0.01, respectively;

²Comparison between patients with colorectal cancer and healthy participants, P < 0.01 and P < 0.01, respectively. ApoA-1: Apolipoprotein A1; ApoB: Apolipoprotein B; FCH: Free cholesterol; HDL-C: High density lipoprotein-cholesterol: LDL-C: Low density lipoprotein-cholesterol; TCH: Total cholesterol; TG: Triglyceride.